| Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the … T Vos, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ... The Lancet 390 (10100), 1211-1259, 2017 | 5661 | 2017 |
| Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 M Naghavi, AA Abajobir, C Abbafati, KM Abbas, F Abd-Allah, SF Abera, ... The lancet 390 (10100), 1151-1210, 2017 | 4909 | 2017 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 … SI Hay, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ... The Lancet 390 (10100), 1260-1344, 2017 | 1723 | 2017 |
| US health care spending by payer and health condition, 1996-2016 JL Dieleman, J Cao, A Chapin, C Chen, Z Li, A Liu, C Horst, A Kaldjian, ... Jama 323 (9), 863-884, 2020 | 828 | 2020 |
| Developmental disabilities among children younger than 5 years in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 BO Olusanya, AC Davis, D Wertlieb, NY Boo, MKC Nair, R Halpern, ... The Lancet Global Health 6 (10), e1100-e1121, 2018 | 569 | 2018 |
| In-person and telehealth ambulatory contacts and costs in a large US insured cohort before and during the COVID-19 pandemic JP Weiner, S Bandeian, E Hatef, D Lans, A Liu, KW Lemke JAMA network open 4 (3), e212618-e212618, 2021 | 171 | 2021 |
| US health care spending by race and ethnicity, 2002-2016 JL Dieleman, C Chen, SW Crosby, A Liu, D McCracken, IA Pollock, ... Jama 326 (7), 649-659, 2021 | 60 | 2021 |
| Growth-altering microbial interactions are responsive to chemical context A Liu, AM Archer, MB Biggs, JA Papin PLoS One 12 (3), e0164919, 2017 | 18 | 2017 |
| Healthcare spending in US emergency departments by health condition, 2006–2016 KW Scott, A Liu, C Chen, AS Kaldjian, AK Sabbatini, HC Duber, ... PLoS one 16 (10), e0258182, 2021 | 16 | 2021 |
| Assessing catastrophic health expenditures among uninsured people who seek care in US hospital-based emergency departments KW Scott, JW Scott, AK Sabbatini, C Chen, A Liu, JL Dieleman, HC Duber JAMA health forum 2 (12), e214359-e214359, 2021 | 9 | 2021 |
| How to analyze and improve the usability of insurer price transparency data Y Wang, Y Wang, A Liu, GF Anderson, G Bai Health Affairs Forefront, 2023 | 2 | 2023 |
| Filgrastim and infliximab biosimilar uptake in Medicare Advantage compared with Traditional Medicare, 2016-2019 A Liu, A Xuan, M Socal, G Anderson, KE Anderson Journal of Managed Care & Specialty Pharmacy 30 (1), 15-21, 2024 | 1 | 2024 |
| Role of Patient Sorting in Avoidable Hospital Stays in Medicare Advantage vs Traditional Medicare JF Xu, KE Anderson, A Liu, BJ Miller, D Polsky JAMA Health Forum 4 (11), e233931-e233931, 2023 | 1 | 2023 |
| Patterns of manufacturer coupon use for prescription drugs in the US, 2017-2019 SY Kang, A Liu, G Anderson, GC Alexander JAMA Network Open 6 (5), e2313578-e2313578, 2023 | 1 | 2023 |
| Estimating health care delivery system value for each US state and testing key associations JL Dieleman, AS Kaldjian, M Sahu, C Chen, A Liu, A Chapin, KW Scott, ... Health services research 57 (3), 557-567, 2022 | 1 | 2022 |
| Medicare Advantage plan characteristics associated with sorting their beneficiaries to providers that generate fewer avoidable hospital stays J Xu, KE Anderson, A Liu, D Polsky Health Services Research, 2024 | | 2024 |
| Evaluating Managed Care and Pricing Strategies in Medicare Advantage: Evidence from Macular Degeneration A Liu Johns Hopkins University, 2024 | | 2024 |
| Utilization of Manufacturer-Sponsored Coupons for Prescription Drugs in the United States SY Kang, A Liu, G Anderson, GC Alexander 2023 APPAM Fall Research Conference, 2023 | | 2023 |
| Incorporating Added Therapeutic Benefit and Domestic Reference Pricing Into Medicare Payment for Expensive Part B Drugs KE Anderson, MJ DiStefano, A Liu, TJ Mattingly II, MP Socal, ... Value in Health 26 (9), 1381-1388, 2023 | | 2023 |
| Examining Price Variation for Physician Administered Macular Degeneration Drugs Among Commercial Health Plans, Evidence from 2023 Insurer Disclosed Price Transparency Data A Liu, Y Wang, Y Wang, G Anderson, J Levy 2023 Annual Research Meeting, 2023 | | 2023 |
Joseph L DielemanInstitute for Health Metrics and EvaluationVerified email at uw.edu
